Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 60760-726

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 60760-726). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (96f45871 7175 49d8 8374 Dfa2978d38c7 01)

Chemical structure of atorvastatin calcium trihydrate, showing the molecular arrangement of the active ingredient including its aromatic rings, hydroxyl groups, and calcium ion association.*

FDA Label Image

Figure1 (96f45871 7175 49d8 8374 Dfa2978d38c7 02)

A line graph comparing the cumulative incidence (%) of an outcome over 3.5 years for Atorvastatin versus Placebo. The graph shows two lines: a solid line for Atorvastatin and a dashed line for Placebo, with the Placebo group showing consistently higher cumulative incidence. The x-axis represents time in years, and the y-axis represents cumulative incidence percentage. The graph includes a hazard ratio (HR=0.64) and a p-value (0.0005).*

FDA Label Image

Figure2 (96f45871 7175 49d8 8374 Dfa2978d38c7 03)

A line chart showing cumulative hazard percentage over time up to 5 years for Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through 4 years of follow-up in years, and the y-axis represents cumulative hazard percentage. Two lines compare Atorvastatin (solid line) and placebo (dashed line) with Atorvastatin showing a lower cumulative hazard. A hazard ratio (HR) of 0.63 with confidence interval (0.48-0.83) and p-value 0.001 is noted.*

FDA Label Image

Figure3 (96f45871 7175 49d8 8374 Dfa2978d38c7 04)

A line graph comparing the percentage of subjects experiencing a major cardiovascular event over 5 years between two doses of Atorvastatin (10 mg and 80 mg). The X-axis represents time to first major cardiovascular endpoint (years), and the Y-axis represents the percentage of subjects experiencing the event. The graph includes hazard ratio (HR) 0.78 with confidence interval and a P-value of 0.0002.*

FDA Label Image

60760-726-30 (Atorvastatin 60760 726 30)

Atorvastatin Calcium 40 mg tablets, USP, quantity 30, labeled with NDC 60760-726-30. Manufactured by Lifestar Pharma LLC, Mahwah, NJ, USA, made in India. Packaged by St. Mary's Medical Park Pharmacy, Oro Valley, AZ 85737. Label includes storage instructions to keep at controlled room temperature, 15°-30°C (59°-86°F).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.